Allied Market Research
Biopharmaceutical Logistics Market

Biopharmaceutical Logistics Market

Size, Share, Competitive Landscape and Trend Analysis Report by Products Type (Cold chain logistics, Non-cold chain logistic), by Transport Service Type (Transportation, Warehouse and storage) and by End Users (Pharmaceuticals, Biopharmaceuticals, Pharmacies, Hospitals, Clinics, Supermarkets, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A10889
Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.


Biopharmaceutical logistics is the logistics of pharmaceuticals, medical and surgical supplies, vaccine, medical devices and equipment, and other products needed to support doctors, nurses, and other health and dental care providers. Because its final customers are responsible for the lives and health of their patients, Biopharmaceutical logistics is unique in that it seeks to optimize effectiveness rather than efficiency. Biopharmaceutical logistics functions comprise an important part of the health care system: after staff costs, medical supplies are the single most expensive component of health care. To drive costs out of the health-care sector, medical logistics providers are adopting supply chain management theories.With rapid technological advancements in logistics is also boosting the growth of the market. Technologies such as data mining, mobile cloud solutions, and real time monitoring are the factors that have contributed into the growth of the market positively. Furthermore, these monitoring solutions assist the logistic companies by providing alerts in order to procure information to execute contingency plans.

Covid-19 Scenario analysis:

The recent Coronavirus (COVID-19) outbreak is having an impact on the logistics industry and is set to cause more disruptions to the calendar. The COVID-19 outbreak that started engulfing various nations across the globe is forcing governments, national and international authorities to take unprecedented measures such as lockdown of cities and restricting the movement of people to check and control the exponential spread of the pandemic. This has consequently affected global trade and supply chain, which has come to almost a standstill. Most countries have restricted or stopped international flights and air travel, which has led to a deferred slowdown as far as the movement of goods are concerned. This has in turn shrunk the air freight capacity limited to the available and operational cargo aircraft and ferry passenger flights carrying only cargo. The shipping sector has also been hit as vessels are placed under quarantine for weeks before being allowed into the ports thereby slowing down processes. Shipping containers are stuck at the ports and on transit at state borders. This is creating an inconvenience in the biopharmaceutical logistic market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact analysis:


Increased need for cold chain logistics:

A cold chain is a temperature-controlled supply chain which is required to preserve and maintain perishable products like food items, chemicals and now, pharmaceutical products. It involves constant refrigeration of the product from the time of its production, through its transportation, handling and storage, right up to delivery. Pharmaceutical cold chain management is an important aspect of the supply chain in the healthcare industry. The cold chain logistics services help the pharmaceutical and healthcare industries maintain a continual stock of drugs from suppliers and distributors across varied locations. Historically the pharmaceutical industry was not a big consumer of cold chain logistics. This was because a majority of its drugs do not need to be stored or transported in a temperature controlled environment. It is only in the recent past that there has been an eruption of cold chain activities due to the growing acceptance of a new class of drugs called biologics. Even though biologics have recently been introduced in the world of medicine, they have already taken the market by storm. Biologics excel not only in terms of their treatment capability, but also in terms of the demands they are placing on the pharmaceutical supply chain as most biologics require both temperature and time-controlled distribution and this need is driving the biopharma logistics market.

Growth of the pharm market:

The pharmaceutical industry includes companies involved in the manufacturing and development of prescription drugs and over-the-counter products that are used to prevent illnesses in humans or animals. The global pharmaceutical market is expected to overcome $1.5 trillion by 2023, from the $1.2 trillion of 2018. Competition in biosimilars is also expected to increase by three times, while specialty share of total medicine spending will reach 50% by 2023 in most developed markets.Growing upsurge in the production of biologics, vaccine, hormone treatments and complex proteins that require cold chain shipment has further propelled the growth of the market. Hence, transportation and delivery of pharmaceutical products that require a specific temperature witnessed a considerable growth of biopharmaceutical logistics market. Furthermore, the growing demand for outsourcing transportation services has significantly grown over the past one decade. This is because various bio pharm companies are undergoing an agreement or outsourcing logistics to service providers in order to reduce the overall operating cost that has in turn lower down the pharmaceutical products. Strong biopharmaceutical sales, temperature sensitivity, biosimilars launches and increasing outsourcing trends are expected to be the catalysts in driving the global biopharmaceutical logistics market in the coming years.

Regional analysis:

The American and European healthcare industry is observing continuous innovation and investment. As the region emerges from the constraints of the economic downturn, it remains imperative to ensure that investment and resources are correctly harnessed, as the average number of drugs being approved for human use has decreased significantly in recent times. With this decline in getting drugs to market post research and development (R&D), logistics companies should consider how they can ensure investment is used as effectively as possible. For the European healthcare and pharm industries, trends and innovations are of high importance in achieving this. Whether to help ensure better quality and longer life expectancy or return on investment potential, healthcare companies need to keep one step ahead of consumer requirements. This will ensure drugs and pharmaceutical products continue to fulfil society’s demand and that supporting services mirror this requirement accordingly.


The drug makers in the US and other industrialised nations are producing more in emerging markets, as well as selling into more overseas markets. While globalisation has encouraged the development of dual-sourcing of biopharmaceuticals and helped make biosimilars a possibility in some markets, it has also increased security risk to shipments.

The high cost of logistics is also a restrain to the market.

Key benefits of the report:

  • This study presents the analytical depiction of the global Biopharmaceuticals logistics industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Biopharmaceuticals logistics market share.
  • The current market is quantitatively analyzed to highlight the global Biopharmaceuticals logistics market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global Biopharmaceuticals logistics market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Biopharmaceuticals logistics Market research report:

  • What are the leading market players active in the Biopharmaceuticals logistics market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Biopharmaceutical Logistics Market Report Highlights

Aspects Details
By Products Type
  • Cold chain logistics
  • Non-cold chain logistic
By Transport Service Type
  • Transportation
    • Air freight
    • Sea freight
    • Overland transportation
  • Warehouse and storage
By End Users
  • Pharmaceuticals
  • Biopharmaceuticals
  • Pharmacies
  • Hospitals
  • Clinics
  • Supermarkets
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players C.H. Robinson Worldwide, Inc.,, Ceva Logistics LLC,, XPO Logistics, Inc., Panalpina World Transport Ltd,, Kuehne + Nagel International AG,, Deutsche Post DHL Group,, Panalpina Group,, United Parcel Service, Inc.,, Fedex Corporation,, Amerisource Bergen Corporation,

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Biopharmaceutical Logistics Market

Start reading.
This Report and over 71,224+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690  $3,321
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820  $4,947
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540  $5,559
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870  $7,896
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports
*Terms and Conditions Apply

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save the time of readers